Share-based Payment Arrangement, Expense in USD of Peak Bio, Inc. from 2021 to Q3 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of expense for award under share-based payment arrangement. Excludes amount capitalized.
Summary
Peak Bio, Inc. quarterly/annual Share-based Payment Arrangement, Expense history and change rate from 2021 to Q3 2024.
  • Peak Bio, Inc. Share-based Payment Arrangement, Expense for the quarter ending 30 Sep 2024 was $0.000, a 100% decline year-over-year.
  • Peak Bio, Inc. Share-based Payment Arrangement, Expense for the twelve months ending 30 Sep 2024 was -$69.3K, a 114% decline year-over-year.
  • Peak Bio, Inc. annual Share-based Payment Arrangement, Expense for 2023 was $275K, a 50.8% decline from 2022.
  • Peak Bio, Inc. annual Share-based Payment Arrangement, Expense for 2022 was $560K, a 11353% increase from 2021.
Share-based Payment Arrangement, Expense, Trailing 12 Months (USD)
Share-based Payment Arrangement, Expense, Quarterly (USD)
Share-based Payment Arrangement, Expense, YoY Quarterly Change (%)
Share-based Payment Arrangement, Expense, Annual (USD)
Share-based Payment Arrangement, Expense, YoY Annual Change (%)

Peak Bio, Inc. Quarterly Share-based Payment Arrangement, Expense (USD)

Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q3 2024 -$69.3K $0 -$76.8K -100% 01 Jul 2024 30 Sep 2024 10-Q 12 Nov 2024
Q2 2024 $7.48K $0 -$133K -100% 01 Apr 2024 30 Jun 2024 10-Q 23 Aug 2024
Q1 2024 $141K $30.5K -$134K -81.5% 01 Jan 2024 31 Mar 2024 10-Q 23 Aug 2024
Q4 2023 $275K -$99.8K -$228K -178% 01 Oct 2023 31 Dec 2023 10-K 06 Aug 2024
Q3 2023 $503K $76.8K -$81.8K -51.6% 01 Jul 2023 30 Sep 2023 10-Q 12 Nov 2024
Q2 2023 $585K $133K -$32.3K -19.5% 01 Apr 2023 30 Jun 2023 10-Q 23 Aug 2024
Q1 2023 $617K $165K +$57K +52.8% 01 Jan 2023 31 Mar 2023 10-Q 23 Aug 2024
Q4 2022 $560K $128K 01 Oct 2022 31 Dec 2022 10-K 06 Aug 2024
Q3 2022 $159K 01 Jul 2022 30 Sep 2022 10-Q 25 Jun 2024
Q2 2022 $166K 01 Apr 2022 30 Jun 2022 10-Q 18 Aug 2023
Q1 2022 $108K 01 Jan 2022 31 Mar 2022 10-Q 12 Jul 2023

Peak Bio, Inc. Annual Share-based Payment Arrangement, Expense (USD)

Period Value YoY Chg Change % Start Date End Date Report Filed
2023 $275K -$285K -50.8% 01 Jan 2023 31 Dec 2023 10-K 06 Aug 2024
2022 $560K +$555K +11353% 01 Jan 2022 31 Dec 2022 10-K 06 Aug 2024
2021 $4.89K 01 Jan 2021 31 Dec 2021 10-K 29 Jun 2023
* An asterisk sign (*) next to the value indicates that the value is likely invalid.